Transgenic mice overexpressing human wild-type or A53T mutant α-synuclein have recapitulated many features of Parkinson’s disease, such as impaired motor function, abnormal protein aggregation, and neuronal degeneration [14–17]. Here, SNCA is linked to Parkinson disease.